There are 15 resources available
Rationale and development of PARPi adjuvant versus advanced or relapse: Ovary and breast examples
Presenter: F. André, FR and I. Ray-Coquard, FR
Session: Session 3 – Comparing efficacy of PARP inhibition across tumour types
Resources:
Slides
Webcast
What did we learn from Phase I trials with PARPi?
Presenter: J. Mateo, ES
Session: Session 3 – Comparing efficacy of PARP inhibition across tumour types
Resources:
Slides
Webcast
Testing optimization in clinical practice
Presenter: K. Van De Vijver, BE
Session: Session 4 – Clinical practices in routine
Resources:
Slides
Webcast
Toxicity management cross vision
Presenter: I. Labidi-Galy, CH
Session: Session 4 – Clinical practices in routine
Resources:
Slides
Webcast
New designs, new combinations and new indications exploring the benefit of PARPi
Presenter: J. Mateo, ES
Session: Session 5 – Future directions of PARP inhibition
Resources:
Slides
Webcast